Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane Sedation During Primary PCI
NCT00971607Phase 2Completed
- Start
- May 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sevoflurane in ST elevation myocardial infarction (STEMI) (2 arms). Primary endpoint: Infarct size by area under the curve of cardiac markers at 3 days. Started May 2009; status: completed.
02
Drugs
sevoflurane
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00971607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00971607.